This inventor holds 1 USPTO granted patent. Top assignee: S O 'Pharmachim'. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: The Innovative Contributions of Anastasia M Stoyanova
Introduction
Anastasia M Stoyanova is a notable inventor based in Sofia, Bulgaria. She has made significant contributions to the field of pharmaceuticals, particularly with her innovative antihypoxic drug. Her work demonstrates a commitment to advancing medical treatments and improving patient outcomes.
Latest Patents
Anastasia holds a patent for an antihypoxic drug and method of its application. This drug, which exhibits verebroprotective and hepatoprotective actions, contains piracetam and orotic acid or their pharmaceutically tolerable salts in a weight ratio ranging from 500:1 to 1:2. The drug is designed for the treatment of acute and chronic diseases, as well as exogenic intoxications, with daily doses varying from 0.150 to 50 g and from 0.030 to 0.30 g of both components. Clinical data supports the synergistic effect of this combination in providing antihypoxic action. The drug can be administered both orally and parenterally, with oral therapy options including tablets, capsules, pills, solutions, and emulsions. Parenteral therapy is recommended for severe diseases and acute exogenic intoxications that lead to complex injuries of the organism.
Career Highlights
Anastasia's career is marked by her dedication to research and development in the pharmaceutical industry. She is currently associated with S O Pharmachim, where she continues to innovate and contribute to the field. Her work has the potential to impact many lives by providing effective treatment options for various medical conditions.
Collaborations
Anastasia collaborates with talented individuals such as Ani I Genova and Milka P Nikolova. These partnerships enhance her research efforts and contribute to the success of her projects.
Conclusion
Anastasia M Stoyanova's innovative work in developing an antihypoxic drug showcases her expertise and commitment to improving healthcare. Her contributions are significant in the realm of pharmaceuticals, and her ongoing research promises to yield further advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile